Ryan focuses on growth equity and late-stage venture investments in healthcare, including healthcare services, healthcare IT, medical devices, and digital health. He is actively involved with Norwest’s investments in American Endovascular, Blue Cloud, Elligo Health Research, Kyo (formerly Gateway Learning Group), Mindful Health Solutions, Onsite Dental, Petabyte, Rivermend Health, TARGET PharmaSolutions, Capsugel (acquired by Lonza), Crossover Health (acquired by Gurnet Point Capital), and iCardiac (acquired by ERT).
Before joining Norwest, Ryan was an investment banking analyst in the Leveraged Finance Group at Bank of America Merrill Lynch. In this role, he analyzed and executed mergers and acquisitions, leveraged buyouts, financings, and other business development opportunities across a wide range of industries. Prior to his time at Bank of America Merrill Lynch, Ryan co-founded and ran a dietary supplement company.
Ryan obtained a bachelor of science degree in business management, with a concentration in economics, from Babson College.